DJIA 17,416.85 225.48 1.31%
NASDAQ 4,683.41 45.41 0.98%
S&P 500 2,021.25 19.09 0.95%
market minute promo

24.49 24.49 (0.00%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

IDIX $24.49 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.00
Previous Close $0.00
Daily Range $0.00 - $0.00
52-Week Range $0.00 - $0.00
Market Cap $3.7B
P/E Ratio 0.00
Dividend (Yield) $0.00 (0.0%)
Volume 0
Average Daily Volume 0
Current FY EPS -$0.97

Sector

Healthcare

Industry

Drugs

Idenix Pharmaceuticals, Inc. (IDIX) Description

A biopharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of human viral and other infectious diseases with operations in the United States and Europe. Website: http://www.idenix.com/

News & Commentary

Biotech M&A: Do We Need a New Driver?

Hepatitis C acquisitions like we've seen from Gilead, Bristol-Myers Squibb, and Merck can't last forever.

The New Baupost Biotech Picks

Why Did Baupost Double Its Stake In Keryx Biopharmaceuticals?

10 Nasdaq stocks with returns of at least 240% in 2014

Buying Biotech

Biotech ETFs Hitting New Highs On Takeover News (FBT, PBE, ITMN)

UPDATE: Deutsche Bank Initiates Coverage On Merck

Prem Watsa Buys 4 New Stocks

Arrowhead's Hep B Phase 2a Topline Data Imminent - 'Transformational' Potential

Merck: Should You Buy It?

Gilead: A Growth Story

See More IDIX News...

IDIX's Top Competitors

IDIX $24.49 (0.00%)
Current stock: IDIX
AMGN $156.37 (1.12%)
Current stock: AMGN
GILD $104.15 (1.66%)
Current stock: GILD
BIIB $353.25 (0.59%)
Current stock: BIIB